SCHEMBL2064134

SCHEMBL2064134

OCc1c(F)ccc(-c2ccc3nc(-c4ccc(F)cc4)cn3c2)c1F

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR4A2 P43354 3/20 0.84
▸ ALDH1A3 P47895 8/20 0.53
▸ NPC1 O15118 4/20 0.46
▸ RAB9A P51151 4/20 0.46
▸ APP P05067 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ KCNH2 Q12809 1/20 0.45
▸ ALDH1A1 P00352 5/20 0.43
▸ ALDH1A2 O94788 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ MITF O75030 1/20 0.40
▸ KDM5A P29375 1/20 0.40
▸ KDM5C P41229 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ PAX8 Q06710 1/20 0.40
▸ CLK1 P49759 1/20 0.40
▸ DYRK1A Q13627 1/20 0.40
▸ POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2062937 0.92 NR4A2 (0.83) NR4A2ALDH1A3NPC1RAB9AAPP
SCHEMBL2064008 0.92 NR4A2 (1.00) NR4A2ALDH1A3NPC1RAB9AAPP
SCHEMBL2063035 0.90 NR4A2 (0.72) NR4A2ALDH1A3NPC1RAB9AAPP
SCHEMBL3430036 0.89 NR4A2 (0.79) NR4A2ALDH1A3NPC1RAB9AAPP
SCHEMBL2062962 0.89 NR4A2 (0.79) NR4A2ALDH1A3NPC1RAB9AAPP
SCHEMBL2063316 0.88 NR4A2 (0.76) NR4A2ALDH1A3NPC1RAB9AAPP
SCHEMBL2065205 0.88 NR4A2 (0.76) NR4A2ALDH1A3NPC1RAB9AAPP
SCHEMBL2065193 0.87 NR4A2 (0.74) NR4A2ALDH1A3NPC1RAB9AAPP
SCHEMBL2064734 0.86 NR4A2 (0.73) NR4A2ALDH1A3NPC1RAB9ACYP2C9
SCHEMBL2063642 0.86 NR4A2 (0.73) NR4A2ALDH1A3NPC1RAB9ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2262803-B1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[L,2-A] PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2012-10-17 — — EP claimed
US-8148370-B2 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof SANOFI-AVENTIS (FR) 2012-04-03 — — US claimed
US-20110065699-A1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-03-17 — — US claimed
EP-2262803-B1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[L,2-A] PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI SA (FR) 2012-10-17 — — EP disclosed
US-8148370-B2 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[1,2-a]pyridines, and preparation and therapeutic use thereof SANOFI-AVENTIS (FR) 2012-04-03 — — US disclosed
US-20110065699-A1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF SANOFI-AVENTIS (FR) 2011-03-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065699-A1 POLYSUBSTITUTED DERIVATIVES OF 2-ARYL-6-PHENYL-IMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF ABL1, JAK2, REN NR4A2 1531/4885ALDH1A3 1255/4885NPC1 1125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback